References
1. Abdulghani S, Moretti F, Gruslin A, Grynspan D. Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2017;39(8):676-681. doi:10.1016/j.jogc.2017.03.089
2. Heller DS, Tellier R, Pabbaraju K, et al. Placental Massive Perivillous Fibrinoid Deposition Associated with Coxsackievirus A16—Report of a Case, and Review of the Literature. Pediatr Dev Pathol. 2016;19(5):421-423. doi:10.2350/15-10-1726-CR.1
3. Faye-Petersen OM, Ernst LM. Maternal Floor Infarction and Massive Perivillous Fibrin Deposition. Surg Pathol Clin. 2013;6(1):101-114. doi:10.1016/j.path.2012.10.002
4. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure.BJOG Int J Obstet Gynaecol. 2003;110(3):292-295.
5. Taweevisit M, Thawornwong N, Thorner PS. Massive Perivillous Fibrin Deposition Associated With Placental Syphilis: A Case Report. Pediatr Dev Pathol. 2021;24(1):43-46. doi:10.1177/1093526620957523
6. Yu W, Tellier R, Wright JR. Coxsackie Virus A16 Infection of Placenta with Massive Perivillous Fibrin Deposition Leading to Intrauterine Fetal Demise at 36 Weeks Gestation. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc. 2015;18(4):331-334. doi:10.2350/15-01-1603-CR.1
7. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466-480. doi:10.1038/nrneph.2014.102
8. Burton GJ, Jauniaux E. Placental Oxidative Stress: From Miscarriage to Preeclampsia. J Soc Gynecol Investig. 2004;11(6):342-352. doi:10.1016/j.jsgi.2004.03.003
9. Kim EN, Lee JY, Shim JY, et al. Clinicopathological characteristics of miscarriages featuring placental massive perivillous fibrin deposition.Placenta. 2019;86:45-51. doi:10.1016/j.placenta.2019.07.006
10. Boog G, Le Vaillant C, Alnoukari F, Jossic F, Barrier J, Muller JY. [Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology]. J Gynecol Obstet Biol Reprod (Paris). 2006;35(4):396-404. doi:10.1016/s0368-2315(06)76411-0
11. Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2016;29(6):855-862. doi:10.3109/14767058.2015.1022864
Acknowledgements: Ms. Mari Kiedysz, MS, PA (ASCP)CM and Dina Hassan, MD for gross and microscopic pathology assistance.
Disclosure of Interests: The authors have no disclosures.
Contribution to authorship: Baillie Bronner worked on literature review, writing the case, and getting patient consent. Margaret Schermerhorn assisted in literature review and drafting of the case. Samantha de los Reyes worked assisted with literature review, case writing, and mentorship. Drs. Anna McCormick and Juliana Sung reviewed, provided commentary and assistance with writing the case.
Detail of Ethics Approval: No IRB was required for case report, however a signed consent was obtained from the patient.